Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Implitapide Compared With Placebo in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy

NCT00079846 is registered in ClinicalTrials.gov with Medical Research Laboratories International as lead sponsor.

NCT NCT00079846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00079846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Implitapide Compared With Placebo in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy
Lead sponsor
Medical Research Laboratories International
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2003
Completion date
April 30, 2005
Enrollment
60
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

familial hypercholesterolemia